The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound aciclovir and a therapeutically-effective amount of the COX-2 inhibitor diclofenac. The invention is further related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of aciclovir and diclofenac.

A percutaneous absorption promoter for promoting percutaneous absorption of diclofenac sodium, the promoter containing 1-menthyl glyceryl ether and a petroleum-based resin and/or terpene-based resin

A skin patch provided with a support layer and an adhesive layer, wherein the adhesive layer contains diclofenac sodium, dimethyl sulfoxide, and citric acid

A composition for the topical treatment of oropharyngeal cavity disorders comprising an aqueous solution of the salt of diclofenac with trimethamine in which the amount of the said salt is of from 0.1% to 0.2% (w/w) and the pH is adjusted between 7 and 8.

A biodegradable drug implant includes a PLG matrix and a non-steroid anti inflammation drug, for example diclofenac sodium. The implant is inserted into the eye in the anterior chamber, for example in the ciliary sulcus, following eye surgery. A method for treating and or preventing inflammation of the eye following eye surgery includes placing the implant in the anterior portion of the eye.